FDA To Require More Detailed Reporting On Authorized Generics Starting In 2010
This article was originally published in The Pink Sheet Daily
Executive Summary
Changes in the final rule focus on potential changes in the reporting method.
You may also be interested in...
The Shadow Of 2003: Hatch/Waxman Changes May Join Health Reform Bills
The Medicare drug benefit, created in 2003, is casting a long shadow on the health care reform debate of 2009
Authorized Generics: FTC Study May Get Jumpstart; PhRMA Paper Finds No Harm
The Federal Trade Commission's study on the impact of authorized generics could be enhanced under an amendment to the legislation reauthorizing the FDA's Rx user fee program
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.